Abstract
A series of highly functionalized naphthoquinones was prepared by an original tetrakis-SRN1 reaction involving 2,3,6,7-tetrakis(chloromethyl)-5,8-dimethoxynaphthalene-1,4-dione with various nitronate anions and S-centered anions.
Keywords: Naphthoquinone, tetrakis-SRN1, electron transfer reaction, nitronate anions, anthracyclines, sulfones
Letters in Organic Chemistry
Title: First Tetrakis-SRN1 Reaction in Naphthoquinone Series
Volume: 5 Issue: 1
Author(s): Patrice Vanelle, Abdelouahab Beziane, Omar Khoumeri and Thierry Terme
Affiliation:
Keywords: Naphthoquinone, tetrakis-SRN1, electron transfer reaction, nitronate anions, anthracyclines, sulfones
Abstract: A series of highly functionalized naphthoquinones was prepared by an original tetrakis-SRN1 reaction involving 2,3,6,7-tetrakis(chloromethyl)-5,8-dimethoxynaphthalene-1,4-dione with various nitronate anions and S-centered anions.
Export Options
About this article
Cite this article as:
Vanelle Patrice, Beziane Abdelouahab, Khoumeri Omar and Terme Thierry, First Tetrakis-SRN1 Reaction in Naphthoquinone Series, Letters in Organic Chemistry 2008; 5 (1) . https://dx.doi.org/10.2174/157017808783330135
DOI https://dx.doi.org/10.2174/157017808783330135 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation
Current Stem Cell Research & Therapy Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition
Cardiovascular & Hematological Agents in Medicinal Chemistry α-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry Clinical Applicability of Microarray Technology in the Diagnosis, Prognostic Stratification, Treatment and Clinical Surveillance of Cervical Adenocarcinoma
Current Pharmaceutical Design Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
Current Cancer Drug Targets Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs
Current Medicinal Chemistry A New Antitumor Agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)-(4-methoxyphenyl) amine, Loaded in Solid Lipid Nanoparticles: Characterization and Pharmacokinetics
Current Nanoscience Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers
Anti-Cancer Agents in Medicinal Chemistry The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry Significance of Cholinergic and Peptidergic Nerves in Stress-Induced Ulcer and MALT Lymphoma Formation
Current Pharmaceutical Design Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities
Protein & Peptide Letters Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Cancer Stem Cells in Prostate Cancer Chemoresistance
Current Cancer Drug Targets Survey of Functional Activities of Alpha-fetoprotein Derived Growth Inhibitory Peptides: Review and Prospects
Current Protein & Peptide Science The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Current Medicinal Chemistry Synthesis and <i>In Silico</i> Studies of C-4 Substituted Coumarin Analogues as Anticancer Agents
Current Computer-Aided Drug Design Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry